CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of wool in patients with chronic obstructive pulmonary disease

  • Received : 2017.03.22
  • Accepted : 2017.08.21
  • Published : 2017.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to analyze the effect wool in patients with chronic obstructive pulmonary disease. The study was conducted experimentally on 53 patients with chronic obstructive pulmonary disease attending the chest diseases polyclinic of a hospital located in Erzurum. A randomized selection method was used to categorize patients into two groups; a treatment (n = 27), and a control group (n = 26). Patients in the treatment group (pre-test measurements were taken) wore wool vests for a period of three months, while patients in the control group wore cotton vests (placebo) for the same duration; post-test measurements were taken for both groups at the end of the three-month period. The Medical Outcomes Study Short Form 36, the St. George's Respiratory Questionnaire, and pulmonary function tests were used to collect data. Results concluded that there was a significant decrease (p < 0.05) in the overall score of the St. George's Respiratory Questionnaire, and the symptom, effect, and activity mean scores, while there was a significant increase (p < 0.05) in the SF-36 physical functioning, general health, bodily pain, role physical, vitality, role emotional, social functioning, mental health, physical and mental component summary mean scores of patients in the treatment group. Results of the study concluded that the symptoms, activity, disease effectiveness, and quality of life improved in patients that wore wool vests.

Keywords

References

  1. Burge PS. Prevention of Exacerbations. How Are We Doing and Can We Do Better? Proc Am Thorac Soc. 2006;3:257-261. https://doi.org/10.1513/pats.200511-117SF
  2. Cakircali E. Fundamental Principles and Applications in Nursing. (Izmir, Turkey: Ege Uni Press), 1996, pp. 99-106.
  3. Donaldson GC, Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in chronic obstructive pulmonary disease. chest. 2012;141:94-100. https://doi.org/10.1378/chest.11-0281
  4. Donaldson GC, Seemungal T, Jeffries DJ, Wedzicha JA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13:844-849. https://doi.org/10.1034/j.1399-3003.1999.13d25.x
  5. Fromer L. Diagnosing and treating COPD: understanding the challenges and finding solutions. Int J Gen Med. 2011;4:729-39.
  6. Giesbrecht GG. The respiratory system in a cold environment. Aviat Space Environ Med. 1995;66:890-902.
  7. GOLD 2016. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease, updated 2016.
  8. Gooneratne NS, Patel NP, Corcoran A. Chronic Obstructive Pulmonary Disease Diagnosis and Management in Older Adults. J Am Geriatr Soc.2010;58:1153-1162. https://doi.org/10.1111/j.1532-5415.2010.02875.x
  9. Gruffydd-Jones K, Loveridge C. The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines? Prim Care Respir J. 2011;20:199-204. https://doi.org/10.4104/pcrj.2011.00011
  10. Gurcum HB. Textile Materials Science. (Ankara, Turkey: Graphic Offset), 2005, pp. 72-79.
  11. Guyton AC, Hall JE. Medical physiology. In: Cavusoglu H, eds. 10th Publishing. Textbook of Medical Physiology. (Istanbul, Turkey: Nobel Tip Kitabevi), 2001, pp. 822-825.
  12. Jones PW, Quirk FH, Baveystock CM. The St. George's respiratory questionnaire. Respir Med. 1991;85:25-31. https://doi.org/10.1016/S0954-6111(06)80166-6
  13. Kocyigit H, Aydemir O, Fisek G, Olmez N, Memis A. Short Form-36 (SF-36) the reliability and validity of the Turkish version. Drug and Therapeutics Journal. 1999;12:102-106.
  14. Komisyon. Textile Technology I-II. 2nd ed. (Istanbul, Turkey: Milli Egitim Press), 1996, pp. 53-71.
  15. Koskela HO, Koskela AK, Tukiaineu HO. Bronchoconstriction due to cold weather in COPD. The roles of direct airway effects and cutaneous reflex mechanisms. Chest. 1996;110:632-636. https://doi.org/10.1378/chest.110.3.632
  16. Kotaniemi JT, Latvala J, Lundback B, Sovijarvi A, Hassi J, Larsson K. Does living in a cold climate or recreational skiing increase the risk for obstructive respiratory diseases or symptoms? Int J Circumpolar Health. 2003;62:142-157. https://doi.org/10.3402/ijch.v62i2.17548
  17. Kotaniemi JT, Pallasaho P, Sovijarvi AR, Laitinen LA, Lundback B. Respiratory symptoms and asthma in relation to cold climate, inhaled allergens, and irritants: a comparison between northern and southern Finland. J Asthma. 2002;39:649-658. https://doi.org/10.1081/JAS-120014930
  18. Meguro M, Barley EA, Spencer S, Jones PW. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest. 2007;32:456-463.
  19. Onlu N. Effects of New Features and Fashion imparted to wool fabric. Msc Thesis, (Izmir, Turkey: Dokuz Eylul University, Institute of Social Sciences), 1995.
  20. Osman LM, Ayres JG, Garden C, Reglitz K, Lyon J, Douglas JG. Home warmth and health status of COPD patients. Eur J Public Health. 2008;18:399-405. https://doi.org/10.1093/eurpub/ckn015
  21. Postma D, Anzueto A, Calverley P, Jenkins C, Make BJ, Sciurba FC, Similowski T, van der Molen T, Eriksson G. A new perspective on optimal care for patients with COPD. Prim Care Respir J. 2011;20:205-209. https://doi.org/10.4104/pcrj.2011.00041
  22. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;15;176:532-555. https://doi.org/10.1164/rccm.200703-456SO
  23. Tasci C, Arik D, Ucar E, Ozkan M, Tozkoparan E. Inpatients Retrospective Evaluation of COPD patients (One-Year Follow-Up). J Clin Analytical Med. 2011;2:4-6.
  24. Ulusoy F, Gorgulu S. Fundamentals of Nursing, Basics, Principles and Methods. (Ankara, Turkey: TDFO limited company press), 1997, pp. 145-151.
  25. Ware JE. SF-36 Health Survey Update. Spine. 2000;25:3130-3139. https://doi.org/10.1097/00007632-200012150-00008
  26. Wedzicha JA, Donaldson GC, Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48:1204-1213.
  27. Yazicioglu Y. Fibre Technologies. (Ankara, Turkey: Gazi University Press), 2000, pp. 98-131.
  28. Yildirim N. Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD. Journal of Tuberculosis and Thoracic. 2010;58:192-201.